abstract |
In the present invention, the formula (I): (Wherein, R 1 to R 3 and L are as in is as described herein) compounds, and their pharmaceutically acceptable salts, enantiomers or diastereomers as well as the compound It relates to a composition comprising, and a method of using the compound. |